MIDAS TIPS UPDATE: Share price has slimmed down a little - but OptiBiotix's profile is set to expand
In 2015, OptiBiotix Health was a darling of the market. Midas tipped the shares in July at 33½p and by the end of the year, they were 77½p. Since then, the performance has been pedestrian and today the stock is 67p, having drifted for most of 2016.
Investors may feel impatient, but now is not the time to sell. OptiBiotix is focused on an area that is increasingly recognised as playing a fundamental role in our health and wellbeing, the business is expected to expand considerably over the next two to three years and the shares should respond accordingly.
Chief executive Stephen O’Hara is an... read more